Guido Reifenberger
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
German Consortium on Aggressive Meningiomas (KAM), Ratliff M, Neidert M, Wirsching H, Harter P, Unterberg A, Herold-Mende C, Jungwirth G, Etminan N, Lamszus K, Westphal M, Hänggi D, Jungk C, Mawrin C, Platten M, Snuderl M, Sahm F, von Deimling A, Preusser M, Weller M, Wick W, Acker T, Reifenberger G, Jones D, Pfister S, Frank S, Hench J, Brandner S, Aldape K, Sen C, Golfinos J, Serrano J, Stein M, Dohmen H, Reuss D, Dogan H, Patel A, Blume C, Euskirchen P, Sill M, Schrimpf D, Berghoff A, Sievers P, Hielscher T, Stichel D, Reinhardt A, Suwala A, Grady C, Jones T, Bridges L, Greenway F, Leu S, Jaunmuktane Z, Schittenhelm J, Ketter R, Bewerunge-Hudler M, Rushing E, Ricklefs F, Baumgarten P, Wefers A, Maas S. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. J Clin Oncol 2021; 39:3839-3852.
Oct 7, 2021Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
Oct 7, 2021J Clin Oncol 2021; 39:3839-3852
German Consortium on Aggressive Meningiomas (KAM), Ratliff Miriam, Neidert Marian Christoph, Wirsching Hans-Georg, Harter Patrick N, Unterberg Andreas, Herold-Mende Christel, Jungwirth Gerhard, Etminan Nima, Lamszus Katrin, Westphal Manfred, Hänggi Daniel, Jungk Christine, Mawrin Christian, Platten Michael, Snuderl Matija, Sahm Felix, von Deimling Andreas, Preusser Matthias, Weller Michael, Wick Wolfgang, Acker Till, Reifenberger Guido, Jones David T W, Pfister Stefan M, Frank Stephan, Hench Jürgen, Brandner Sebastian, Aldape Kenneth D, Sen Chandra, Golfinos John, Serrano Jonathan, Stein Marco, Dohmen Hildegard, Reuss David, Dogan Helin, Patel Areeba, Blume Christina, Euskirchen Philipp, Sill Martin, Schrimpf Daniel, Berghoff Anna S, Sievers Philipp, Hielscher Thomas, Stichel Damian, Reinhardt Annekathrin, Suwala Abigail K, Grady Conor, Jones Timothy, Bridges Leslie R, Greenway Fay E A, Leu Severina, Jaunmuktane Zane, Schittenhelm Jens, Ketter Ralf, Bewerunge-Hudler Melanie, Rushing Elisabeth J, Ricklefs Franz, Baumgarten Peter, Wefers Annika K, Maas Sybren L N
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Sievers P, Etminan N, Ratliff M, Herold-Mende C, Pfister S, Jones D, Weller M, Harter P, Wick W, Preusser M, von Deimling A, Westphal M, Lamszus K, Reifenberger G, Hielscher T, Schrimpf D, Stichel D, Reuss D, Berghoff A, Neidert M, Wirsching H, Mawrin C, Ketter R, Paulus W, Sahm F. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 2020; 140:409-413.
Jul 8, 2020CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Jul 8, 2020Acta Neuropathol 2020; 140:409-413
Sievers Philipp, Etminan Nima, Ratliff Miriam, Herold-Mende Christel, Pfister Stefan M, Jones David T W, Weller Michael, Harter Patrick N, Wick Wolfgang, Preusser Matthias, von Deimling Andreas, Westphal Manfred, Lamszus Katrin, Reifenberger Guido, Hielscher Thomas, Schrimpf Daniel, Stichel Damian, Reuss David E, Berghoff Anna S, Neidert Marian Christoph, Wirsching Hans-Georg, Mawrin Christian, Ketter Ralf, Paulus Werner, Sahm Felix
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
Wolpert F, Weller M, Westphal M, Lamszus K, Neidert M, Roth P, Deenen R, Florea A, Reifenberger G, Happold C, Eisele G. Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells. PloS one 2015; 10:e0139603.
Oct 6, 2015Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
Oct 6, 2015PloS one 2015; 10:e0139603
Wolpert Fabian, Weller Michael, Westphal Manfred, Lamszus Katrin, Neidert Marian Christoph, Roth Patrick, Deenen René, Florea Ana-Maria, Reifenberger Guido, Happold Caroline, Eisele Günter
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
Herrlinger U, Reifenberger G, Bamberg M, Sommer C, Tan T, Meyermann R, Wick W, Hundsberger T, Steinbach J, Kortmann R, Blaschke B, Loeser S, Koch D, Rieger J, Weller M. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006; 24:4412-7.
Sep 20, 2006Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
Sep 20, 2006Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006; 24:4412-7
Herrlinger Ulrich, Reifenberger Guido, Bamberg Michael, Sommer Clemens, Tan Ta-Chih, Meyermann Richard, Wick Wolfgang, Hundsberger Thomas, Steinbach Joachim P, Kortmann Rolf-Dieter, Blaschke Britta, Loeser Simon, Koch Dorothee, Rieger Johannes, Weller Michael